In some cases, if additional glycaemic control is needed, the dose may be increased to 2 mg weekly after at least four weeks on the 1 mg dose
The side effect profiles differ between GLP-1 medications , and your provider can help determine whether any symptoms you experience are injection-related or medication-related
These approaches are common among doctors who specialize in medical weight management, and as such, medical record data can be studied to inform future guidelines and standardization about maintenance-phase dosing in particular
Contact your prescribing physician or pharmacy
For this reason, we ascribe the fat mass signal in our body composition data to ectopic lipid accumulation
If the shortage ends, the legal basis for compounding these drugs will likely cease